RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming binary ...

Investors in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) had a good week, as its shares rose 9.7% to close at US$34.54 ...

Data from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia to be Presented in Plenary Session – – Additional Presentations to Highlight Quality of Life Data from ENERGIZE ...

Q1 2024 Earnings Call Transcript May 2, 2024 Agios Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge ...

Instantly recognizable by its astounding luminous turquoise seas enclosed within soaring craggy bluffs, Greece’s Insta-famous ...

The Pontian Society of Sydney Panagia Soumela is marking its 60th anniversary with a gift to the church of Agios Stefanos, ...

Cantor Fitzgerald raised the price target for the Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock to “an Overweight”. The rating was released on February 08, 2024, according to finviz. The research ...

Paxos is one of the best kept secrets in Greece, and we found the most interesting local to show us around the magnificent ...

Agios Pharmaceuticals will present their latest quarterly figures on May 2.Wall Street predict expect Agios Pharmaceuticals will report losses ...

The Greek island of Kimolos in the Aegean has been awarded with the unofficial title of having the clearest water in the ...

Agios Pharmaceuticals (AGIO) came out with a quarterly loss of $1.45 per share versus the Zacks Consensus Estimate of a loss of $1.64. This compares to loss of $1.47 per share a year ago.

Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $81.5 million in its first quarter. The Cambridge, Massachusetts-based company said it had a loss of $1.45 per share. The results ...